Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
After finishing at $0.77 in the prior trading day, Palisade Bio Inc (NASDAQ: PALI) closed at $0.73, down -5.06%. In other words, the price has decreased by -$5.06 from its previous closing price. On the day, 5.39 million shares were traded.
Ratios:
Our goal is to gain a better understanding of PALI by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.81 and its Current Ratio is at 2.81. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 28 ’24 when Williams Donald Allen bought 1,000 shares for $4.86 per share. The transaction valued at 4,863 led to the insider holds 1,000 shares of the business.
Finley John David bought 1,000 shares of PALI for $4,810 on May 24 ’24. The CEO, CFO, Director now owns 8,437 shares after completing the transaction at $4.81 per share.
Stock Price History:
Over the past 52 weeks, PALI has reached a high of $6.71, while it has fallen to a 52-week low of $0.60. The 50-Day Moving Average of the stock is -3.87%, while the 200-Day Moving Average is calculated to be -65.95%.
Shares Statistics:
A total of 4.40M shares are outstanding, with a floating share count of 4.36M. Insiders hold about 0.81% of the company’s shares, while institutions hold 3.29% stake in the company.
